Combination of ‘omics’ data to investigate the mechanism(s) of hydrazine-induced hepatotoxicity in Rats and to identify potential biomarkers

References

• ALEYASSINE, H. and LEE, S. H. 1971, Inhibition by hydrazine, phenelzine and pargyline of insulin release from rat pancreas. Endocrinology, 89, 125–129.
   PubMedGoogle Scholar
• AMENTA, J. S. and DOMINGUEZ, A. M. 1965, Fatty acid flux and triglyceride secretion in the hydrazine-induced fatty liver. Experimental and Molecular Pathology, 4, 282–302.
   PubMed Web of Science ®Google Scholar
• AMENTA, J. S. and JOHNSTON, E. H. 1962, Hydrazine-induced alterations in rat liver. A correlation of the chemical and histologic changes in acute hydrazine intoxication. Laboratory Investigation, 11, 956–962.
   PubMed Web of Science ®Google Scholar
• ANDERSSON, Y., MAJD, Z., LEFEBVRE, A. M., MARTIN, G., SECHKIN, A. V, KOSYKH, V., FRUCHART, J. C., NAJIB, J. and STAELS, B. 1999, Developmental and pharmacological regulation of apolipoprotein C-II gene expression: comparison with Apo C-I and Apo C-III gene regulation. Arteriosclerosis, Thrombosis and Vascular Biology, 19, 115–121.
   PubMedGoogle Scholar
• BANKA, C. L. 1996, High density lipoprotein and lipoprotein oxidation. Current Opinion in Lipidology, 7, 139–142.
   PubMed Web of Science ®Google Scholar
• BARLOW, P. B., BLACK, M., BRUMMER, D. L., COMSTOCK, G. W, DUBIN, I. N., ENTERLINE, P., GIBSON, M. L, HARDY, G. E., HARREL, J. A., JOHNSTON, R F., KENT, D. C., MARVIN, B. A., McCmo, N. C., MITCHELL, J. R, MOSLEY, J. W., OGASAWARA, F. R., POPPER, H., REICHMAN, L. B. and ZIMMERMAN, H. J. 1974, Preventive therapy of tuberculous infection. American Review of Respiratory Disease, 110, 371–374.
   PubMedGoogle Scholar
• BIANCIFIORI, C. 1970, Hepatomas in CBA/Cb/Se mice and liver lesions in golden hamsters induced by hydrazine sulfate. Journal of the National Cancer Institute, 44, 943–953.
   PubMedGoogle Scholar
• BLAIR, I. A., 1VIANsiwi TINOCO, R, BRODIE, M. J., CLARE, R A., DOLLERY, C. T., TIMBRELL, J. A. and BEEVER, I. A. 1985, Plasma hydrazine concentrations in man after isoniazid and hydralazine administration. Human Toxicology, 4, 195–202.
   Google Scholar
• BRADFORD, M. M. 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein—dye binding. Analytical Biochemistry, 72, 248–254.
   PubMed Web of Science ®Google Scholar
• BUCHMAN, A. L., DUBIN, M., JENDEN, D., MOTJKARZEL, A., ROCH, M. H., RICE, K, GORNBELN, J., AMENT, M. E. and ECKHERT, C. D. 1992, Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Gastroenterology, 102, 1363–1370.
   PubMed Web of Science ®Google Scholar
• BYKOVA, N. V., STENSBALLE, A., EGSGAARD, H., JENSEN, 0. N. and MOLLER, I. M. 2003, Phosphorylation of formate dehydrogenase in potato tuber mitochondria. Journal of Biological Chemistry, 278, 26021–26030.
   Google Scholar
• COOLING, J., BuRrirrr, S. L and BRINDLEY, D. N. 1979, Effects of treating rats with hydrazine on the circulating concentrations of corticosterone and insulin in relation to hepatic triacylglycerol synthesis. Biochemical Society Transactions, 7, 1051–1053.
   PubMedGoogle Scholar
• CORNISH, H. H. 1969, The role of vitamin B6 in the toxicity of hydrazines. Annals of the New York Academy of Sciences, 166, 136–145.
   PubMed Web of Science ®Google Scholar
• CUEBAS, D. A., PHILLIPS, C., ScHwrz, W, CONZELMANN, E. and Novnwv, D. K 2002, The role of alpha-methylacyl-CoA racemase in bile acid synthesis. Biochemical Journal, 363, 801–807.
   PubMedGoogle Scholar
• DAUM, U., LEREN, T. P., [ANGER, C., CHIRAZI, A., CTJLIEN, P., PRITCHARD, P. H., ASSMANN, G. and VON ECKARDsTEIN, A. 1999, Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers. Journal of Lipid Research, 40, 486–494.
   Google Scholar
• DE BACKER, M. D., THURMOND, R L., CARMEN, A. A. and LUYTEN, W. H. M. L 2002, Gene-expression-based responses to drug treatment. Drug News and Perspectives, 15, 155–165.
   PubMedGoogle Scholar
• Di Luzio, N. R, STEGE, T. E. and HOFFMAN, E. 0. 1973, Protective influence of diphenyl-p-phenylenediamine on hydrazine induced lipid peroxidation and hepatic injury. Experimental and Molecular Pathology, 19, 284–292.
   PubMed Web of Science ®Google Scholar
• DURRINGTON, P. N., MACKNESS, B. and MACKNESS, M. I. 2001, Paraoxonase and atherosclerosis. Arteriosclerosis, Thrombosis and Vascular Biology, 21, 473–480.
   PubMed Web of Science ®Google Scholar
• FORTNEY, S. R. 1966, Effect of hydrazine on liver glycogen, arterial glucose, lactate, pyruvate and acid—base balance in the anesthetized dog. Journal of Pharmacology and Experimental Therapeutics, 153, 562–568.
   PubMed Web of Science ®Google Scholar
• FORTNEY, S. R 1967, Effect of hydrazine on carbohydrate metabolism in vivo and in vitro. Aerospace Medicine, 38, 727–731.
   PubMedGoogle Scholar
• FORTNEY, S. R., CI-ARK, D. A. and STEIN, E. 1967, Inhibition of gluconeogenesis by hydrazine administration in rats. Journal of Pharmacology and Experimental Therapeutics, 156, 277–284. GHATINEH, S. and TIMBRELL, J. A. 1994, The biochemical effects and toxicity of hydrazine in cultured rat hepatocytes. Toxicology in Vitro, 8, 393–399.
   Google Scholar
• GHATINEH, S., MORGAN, W, PREECE, N. E. and THVIBRELL, J. A. 1992, A biochemical and NMR spectroscopic study of hydrazine in the isolated rat hepatocyte. Archives of Toxicology, 66, 660–668.
   PubMed Web of Science ®Google Scholar
• GOLD, J. 1987, Hydrazine sulfate: a current perspective. Nutrition and Cancer, 9, 59–66.
   PubMedGoogle Scholar
• HUSSAIN, S. M. and FRAZIER, J. M. 2002, Cellular toxicity of hydrazine in primary rat hepatocytes. Toxicological Sciences, 69, 424–432.
   PubMed Web of Science ®Google Scholar
• HWANG, D. and ISMAIL-BEIGI, F. 2002, Glucose uptake and lactate production in cells exposed to CoC12 and in cells overexpressing the Glut-1 glucose transporter. Archives of Biochemistry and Biophysics, 399, 206–211.
   PubMedGoogle Scholar
• ISMAIL-BEIGI, F. 1993, Metabolic regulation of glucose transport. Journal of Membrane Biology, 135, 1 — 10.
   PubMedGoogle Scholar
• JENNER, A. M. and TIMBRELL, J. A. 1994, Effect of acute and repeated exposure to low doses of hydrazine on hepatic microsomal enzymes and biochemical parameters in vivo. Archives of Toxicology, 68, 240–245.
   PubMed Web of Science ®Google Scholar
• KAMINSKI, D. L., ADAMS, A. and JELLINEK, M. 1980, The effect of hyperalimentation on hepatic lipid content and lipogenic enzyme activity in rats and man. Surgery, 88, 93–100.
   PubMed Web of Science ®Google Scholar
• KARBOWSKI, M., KURONO, C., NISHIZAWA, Y, HORIE, Y., Soil, T. and WAKABAYASHI, T. 1997, Induction of megamitochondria by some chemicals inducing oxidative stress in primary cultured rat hepatocytes. Biochimica et Biophysica Acta, 1349, 242–250.
   PubMed Web of Science ®Google Scholar
• KERSTEN, S. 2002, Peroxisome proliferator activated receptors and obesity. European Journal of Pharmacology, 440, 223–234.
   PubMed Web of Science ®Google Scholar
• KIMBALL, R. F. 1977, The mutagenicity of hydrazine and some of its derivatives. Mutation Research, 39, 111–126.
   PubMed Web of Science ®Google Scholar
• KLATJNIG, J. E., XT_J, Y., BACHOWSKI, S., KETCHAM, C. A., ISENBERG, J. S., KOLAJA, K L., BAKER, T. K, WALBORG, E. F. and STEVENSON, D. E. 1995, Oxidative stress in nongenotoxic carcinogenesis. Toxicology Letters, 82–83, 683–691.
   Google Scholar
• KLEINEKE, J., PETERS, H. and SOLING, H. D. 1979, Inhibition of hepatic gluconeogenesis by phenethylhydrazine (phenelzine). Biochemical Pharmacology, 28, 1379–1389.
   PubMed Web of Science ®Google Scholar
• KLENO, T. G., LEONARDSEN, L. R., KJELDAL, H. 0., LAUSEN, S. M., JENSEN, 0. N. and BAUNSGAARD, D. 2004b, Mechanisms of hydrazine toxicity in rat liver investigated by proteomics and multivariate data analysis. Proteomics, 4, 868–880.
   Google Scholar
• KLENO, T. G., ANDREASEN, C. M., KJELDAL, H. 0., LEONARDSEN, L. R, KROGH, T. N., NIELSEN, P. E, SORENSEN, M. V. and JENSEN, 0. N. 2004a, MALDI MS peptide mapping performance by in-gel digestion on a probe with prestructured sample supports. Analytical Chemistry, 76, 3576–3583.
   Google Scholar
• LEE, C. H., OLSON, P. and EVANS, R. M. 2003, Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology, 144, 2201–2207.
   PubMed Web of Science ®Google Scholar
• LOPEZ-MENDOZA, D. and VILLA-TREvigio, S. 1971, Hydrazine-induced inhibition of amino acid incorporation into rat liver protein. Laboratory Investigation, 25, 68–72.
   PubMed Web of Science ®Google Scholar
• MACKNESS, B., DURRINGTON, P. N., BOULTON, A. J. M., HINE, D. and MACKNESS, M. I. 2002, Serum paraoxonase activity in patients with type I diabetes compared with healthy controls. European Journal of Clinical Investigation, 32, 259–264.
   Google Scholar
• MARTENS, H. and Ns, T. 1993, Multivariate Calibration (New York: Wiley).
   Google Scholar
• MATSUHASHI, T., Liu, X., KARBOWSKI, M., WOZNIAK, M., ANTOSIEWICZ, J. and WAKABAYASHI, T. 1997, Role of free radicals in the mechanism of the hydrazine-induced formation of megamitochondria. Free Radical Biology and Medicine, 23, 285–293.
   PubMedGoogle Scholar
• McCoKrviicK, D. B. and SNELL, E. E. 1961, Pyridoxal phosphokinases. II. Effects of inhibitors. Journal of Biological Chemistry, 236, 2085–2088.
   PubMedGoogle Scholar
• MCLEAN, B. N., ALLEN, J., FERDINANDUSSE, S. and WANDERS, R. J. A. 2002, A new defect of peroxisomal function involving pristanic acid: a case report. Journal of Neurology Neurosurgery and Psychiatry, 72, 396–399.
   PubMedGoogle Scholar
• MEDINA, M. A. 1963, The in vivo effects of hydrazines and vitamin B6 on the metabolism of gamma-aminobutyric acid. Journal of Pharmacology and Experimental Therapeutics, 140, 133–137.
   PubMed Web of Science ®Google Scholar
• MINDEROP, R. H., HOEPPNER, W. and SEITZ, H. J. 1987, Regulation of hepatic glucokinase gene expression. Role of carbohydrates, and glucocorticoid and thyroid hormones. European Journal of Biochemistry, 164, 181–187.
   PubMedGoogle Scholar
• MOLONEY, S. and PROUGH, R. A. 1983, Biochemical toxicology of hydrazines. Reviews in Biochemical Toxicology, 5, 313–348.
   Google Scholar
• NANJI, A. A., FOOT, F. and GRINIUVIENE, B. 1995, Alterations in glucose transporter proteins in alcoholic liver disease in the rat. American Journal of Pathology, 146, 329–334.
   PubMedGoogle Scholar
• NICHOLLS, A. W., HOLMES, E., LINDON, J. C., SHOCKCOR, J. P., FARRANT, R. D., HASELDEN, J. N., DAMMENT, S. J. P., WATERFIELD, C. J. and NICHOLSON, J. K 2001, Metabonomic investigations into hydrazine toxicity in the rat. Chemical Research in Toxicology, 14, 975–987.
   Google Scholar
• NICHOLSON, J. K., CONNELLY, J., LINDON, J. C. and HOLMES, E. 2002, Metabonomics: a platform for studying drug toxicity and gene function. Nature Reviews Drug Discovery, 1, 153–161. NICHOLSON, J. K, FOXALL, P. J., SPRAUL, M., FARRANT, R D. and LINDON, J. C. 1995, 750 MHz and 1H-13C NMR spectroscopy of human blood plasma. Analytical Chemistry, 67, 793–811. NODA, A., Hsu, K. Y, NODA, H., YAMAMOTO, Y. and KUROZUMI, T. 1983, Is isoniazid-hepatotoxicity induced by the metabolite, hydrazine? Journal of UOEH, 5, 183–190.
   Google Scholar
• PACKER, N., WILSON, N., SCHULZ, B., Josm, H., COOPER, C. and KARLSSO NN. 2002, Glycomics: realistic expectations. Glycobiology, 12, 649.
   Google Scholar
• PEDERSEN, S. B., BAK, J. F., HoLcK, P., ScHwrz, 0. and RICHELSEN, B. 1999, Epinephrine stimulates human muscle lipoprotein lipase activity in vivo. Metabolism Clinical and Experimental, 48, 461–464.
   Google Scholar
• PREECE, N. E., GHATINEH, S. and TIMBRELL, J. A. 1990, Course of ATP depletion in hydrazine hepatotoxicity. Archives of Toxicology, 64, 49–53.
   PubMed Web of Science ®Google Scholar
• PREECE, N. E., GHATINEH, S. and TIMBRELL, J. A. 1992, Studies on the disposition and metabolism of hydrazine in rats in vivo. Human and Experimental Toxicology, 11, 121–127.
   PubMed Web of Science ®Google Scholar
• RAY, P. D., HANSON, R L. and LARDY, H. A. 1970, Inhibition by hydrazine of gluconeogenesis in the rat. Journal of Biological Chemistry, 245, 690–696.
   PubMed Web of Science ®Google Scholar
• REDDY, J. K. 2001, Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis. American Journal of Physiology Gastrointestinal and Liver Physiology, 281, G1333—G1339.
   Google Scholar
• ROBERGE, A., GOSSELIN, C. and CHARBONNEAU, R 1971, Effect of hydrazine on urea cycle enzymes in vitro and in vivo. Biochemical Pharmacology, 20, 2231–2238.
   Google Scholar
• SCALES, M. D. C. and TIMBRELL, J. A. 1982, Hydrazine hepatotoxicity 1. Pathological findings. Journal of Toxicology and Environmental Health, 10, 941–953.
   Google Scholar
• SHACHTER, N. S. 2001, Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Current Opinion in Lipidology, 12, 297–304.
   PubMed Web of Science ®Google Scholar
• SILVERSTEIN, R, BHATIA, P. and SVOBODA, D. J. 1989, Effect of hydrazine sulfate on glucose-regulating enzymes in the normal and cancerous rat. Immunopharmacology, 17, 37–43.
   PubMedGoogle Scholar
• SNOECKX, L. H. E. H., CORNELUSSEN, R N., VAN NIEUWENHOVEN, F. A., RENEMAN, R. S. and VAN DER VUSSE, F. 2001, Heat shock proteins and cardiovascular pathophysiology. Physiological Reviews, 81, 1461–1497.
   Google Scholar
• SOUTAR, A. K., GARNER, C. W., BAKER, H. N., SPARROW, J. T, JACKSON, R L., GOTTO, A. M. and SNirrx, L. C. 1975, Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase. Biochemistry, 14, 3057–3064.
   PubMed Web of Science ®Google Scholar
• SREEKUMAR, R., RosArio, B., RASMUSSEN, D. and CHARLTON, M. 2003, Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis. Hepatology, 38, 244–251.
   PubMed Web of Science ®Google Scholar
• STEIN, E. R., CI-ARK, D. A. and FORTNEY, S. R. 1971, Inhibition of glutamic-oxaloacetic transaminases of rat liver by hydrazine. Toxicology and Applied Pharmacology, 18, 274–284.
   Google Scholar
• STEINMETZ, A. and UTERMANN, G. 1985, Activation of lecithin:cholesterol acyltransferase by human apolipoprotein A-IV. Journal of Biological Chemistry, 260, 2258–2264.
   PubMed Web of Science ®Google Scholar
• STENSBALLE, A. and JENSEN, 0. N. 2001, Simplified sample preparation method for protein identification by matrix-assisted laser desorption/ionization mass spectrometry: in-gel digestion on the probe surface. Proteomics, 1, 955–966.
   Google Scholar
• TIMBRELL, J. A., SCAI-ES, M. D. and STREETER, A. J. 1982, Studies on hydrazine hepatotoxicity. 2. Biochemical findings. Journal of Toxicology and Environmental Health, 10, 955–968.
   Google Scholar
• TIMBRELL, J. A. and WATERFIELD, C. J. 1996, Changes in taurine as an indicator of hepatic dysfunction and biochemical perturbations. Studies in vivo and in vitro. Advances in Experimental Medicine and Biology, 403, 125–134.
   PubMedGoogle Scholar
• TOTH, B. 1993, Teratogenic hydrazines: a review. In Vivo, 7, 101–110.
   PubMedGoogle Scholar
• TOTH, B. 1994, A review of cancer risk associated with human exposure to hydrazines. International Journal of Oncology, 4, 231–239.
   PubMedGoogle Scholar
• TYERS, M. and MANN, M. 2003, From genomics to proteomics. Nature, 422, 193–197.
   PubMed Web of Science ®Google Scholar
• UNIX', M. 1999, Difference gel electrophoresis. Biochemical Society Transactions, 27, 547–549.
   PubMedGoogle Scholar
• UNLU, M., MORGAN, M. E. and MINDEN, J. S. 1997, Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis, 18, 2071–2077.
   PubMed Web of Science ®Google Scholar
• WAKABAYASHI, T, YAmAsHrrA, K, ADACHI, K., KAWAL K., IIJIMA, M., GEKKO, K, TSUDZUKI, T., POPINIGIS, J. and MOMOTA, M. 1987, Changes in physicochemical properties of mitochondrial membranes during the formation process of megamitochondria induced by hydrazine. Toxicology and Applied Pharmacology, 87, 235–248.
   Google Scholar
• WATERFIELD, C. J., ASKER, D. S. and TIMBRELL, J. A. 1997a, Triglyceride disposition in isolated hepatocytes after treatment with hydrazine. Chemico-Biological Interactions, 107, 157–172.
   PubMedGoogle Scholar
• WATERFIELD, C. J., DELANEY, J., KERAL M. D. J. and TIMBRELL, J. A. 1997b, Correlations between in vitro and in vitro effects of toxic compounds: Studies with hydrazine. Toxicology in Vitro, 11, 217–227.
   Google Scholar
• WEINHOUSE, S. 1976, Regulation of glucokinase in liver. Current Topics in Cellular Regulation, 11, 1-50. Wom, S., ESBENSEN, K and GELADI, P. 1987, Principal component analysis. Chemometrics and Intelligent Laboratory Systems, 2, 37–57.
   Google Scholar
• ZHANG, Z., STJZTJKI, Y., SHIMOZAWA, N., FTJKTJDA, S., IMAMTJRA, A., TSTJKAMOTO, T., OSUMI, T., FUJIKI, Y, ORLI, T., WANDERS, R J. A., BARTH, P. G., MOSER, H. W, PATON, B. C., BESI-EY, G. T. and KoNDo, N. 1999, Genomic structure and identification of 11 novel mutations of the PEX6 (peroxisome assembly factor-2) gene in patients with peroxisome biogenesis disorders. Human Mutation, 13, 487–496.
   Google Scholar